Provided by Tiger Trade Technology Pte. Ltd.

Ashland

70.57
-0.1200-0.17%
Post-market: 70.570.00000.00%19:30 EDT
Volume:408.77K
Turnover:28.86M
Market Cap:3.23B
PE:61.41
High:71.07
Open:70.56
Low:69.95
Close:70.69
52wk High:78.25
52wk Low:47.12
Shares:45.76M
Float Shares:37.72M
Volume Ratio:0.59
T/O Rate:1.08%
Dividend:1.67
Dividend Rate:2.36%
EPS(TTM):1.15
EPS(LYR):-18.3696
ROE:3.99%
ROA:2.43%
PB:1.73
PE(LYR):-3.84

Loading ...

X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders

GlobeNewswire
·
Yesterday

Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease

GlobeNewswire
·
Oct 07

Ashland sales process advancing, Dealreporter says

TIPRANKS
·
Oct 07

Ashland Price Target Cut to $80.00/Share from $83.00 by UBS

Dow Jones
·
Oct 06

UBS Adjusts Ashland Price Target to $80 From $83, Maintains Buy Rating

MT Newswires Live
·
Oct 05

Ashland price target lowered to $80 from $83 at UBS

TIPRANKS
·
Oct 05

Ashland (ASH), What Is Behind The Fresh Attention?

Simply Wall St.
·
Oct 02

Ashland (ASH) Receives a Buy from Jefferies

TIPRANKS
·
Sep 22

Analysts Are Bullish on These Materials Stocks: Sherwin-Williams Company (SHW), Ashland (ASH)

TIPRANKS
·
Sep 22

Ashland scales Transformed Vegetable Oils technology platform in crop care, launches agrimer™ eco-disperse OD polymeric dispersant

GlobeNewswire
·
Sep 22

Ashland collecting bids in September, Dealreporter says

TIPRANKS
·
Sep 16

Ashland to Host Innovation Day Webcast, Spotlights Technology Platforms Progress

Reuters
·
Sep 14

Ashland to Host Innovation Day Webcast for Analysts, Investors

Reuters
·
Sep 01

Ashland’s New Oral Biologics Excipient Launch Might Change The Case For Investing In Ashland (ASH)

Simply Wall St.
·
Aug 26

Ashland Inc. : Argus Research Raises Target Price to $80 from $64

THOMSON REUTERS
·
Aug 24

Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate

GlobeNewswire
·
Aug 24

Press Release: ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates

Dow Jones
·
Aug 13

Ashland (ASH) Stock Looks Pricey Even If Cash Flow Value Appeals

Simply Wall St.
·
Aug 13

Ashland Now a ‘Gig-Ready’ Community From Kinetic’s Fiber-Optic Network Expansion

GlobeNewswire
·
Aug 12

Prelude Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
Aug 11